John J. Sninsky, Ph.D. is a Translational Science and Medicine consultant with a comprehensive and deep understanding of the development and application of pioneering molecular procedures to the translation of research-grade biomarker assays into clinical-grade clinically adopted diagnostic tests. Following a faculty appointment at Albert Einstein College of Medicine, John joined the team at Cetus that developed polymerase chain reaction (PCR) and applied the powerful technology to clinical virologydiagnostics, notably HIV. He has held senior management positions at Roche, Celera, Quest Diagnostics and CareDx.
He is the author of more than 110 scientific papers including advanced methods in molecular biology, application of the polymerase chain reaction (PCR) to virology and cancer, and genome-wide genetic association studies for multiple common, complex diseases. John advises commercial translation efforts at Stanford University (SPARK) and University of California, San Francisco (CATALYST) and lectures in Diagnostic Regulatory Science at University of California, Berkeley. He is a member of Coronavirus Standards Working Group, an organization focused on developing molecular standards for SARS-CoV-2 (COVID-19).
John serves as a technical advisor for Stop the Spread, with a focus on diagnostics.